Home › Multiple Myeloma › Indiana › Hammond
Multiple Myeloma clinical trials in Hammond, IN
3 studies for Multiple Myeloma are looking for participants at sites in and around Hammond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
RecruitingPhase 1
- Genesis Medical Research, Dyer · 6 mi away
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- Advocate South Suburban Hospital, Hazel Crest · 10 mi away
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- The Community Hospital, Munster · 1 mi away
- Women's Diagnostic Center - Munster, Munster · 1 mi away
- Northwest Oncology LLC, Dyer · 6 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO27 studies
- Rochester, MN24 studies
- St. Louis, MO24 studies
- Columbus, OH24 studies
- Baldwin Park, CA23 studies
- Chicago, IL22 studies
Other studies in Hammond
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer10 studies
- Breast Cancer9 studies
- Heart Failure8 studies
- Colorectal Cancer5 studies
- Ovarian Cancer5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Pancreatic Cancer4 studies
- High Blood Pressure4 studies
- Macular Degeneration4 studies
- COPD3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.